FR2017311B1 - - Google Patents

Info

Publication number
FR2017311B1
FR2017311B1 FR696930103A FR6930103A FR2017311B1 FR 2017311 B1 FR2017311 B1 FR 2017311B1 FR 696930103 A FR696930103 A FR 696930103A FR 6930103 A FR6930103 A FR 6930103A FR 2017311 B1 FR2017311 B1 FR 2017311B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR696930103A
Other languages
French (fr)
Other versions
FR2017311A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2017311A1 publication Critical patent/FR2017311A1/en
Application granted granted Critical
Publication of FR2017311B1 publication Critical patent/FR2017311B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6930103A 1968-09-03 1969-09-03 Medicament preparation for controlled release Granted FR2017311A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75714368A 1968-09-03 1968-09-03
US85066369A 1969-08-15 1969-08-15

Publications (2)

Publication Number Publication Date
FR2017311A1 FR2017311A1 (en) 1970-05-22
FR2017311B1 true FR2017311B1 (en) 1973-01-12

Family

ID=27116338

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6930103A Granted FR2017311A1 (en) 1968-09-03 1969-09-03 Medicament preparation for controlled release

Country Status (4)

Country Link
CA (1) CA927282A (en)
DE (1) DE1944693C3 (en)
FR (1) FR2017311A1 (en)
MY (1) MY7300483A (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE28316E (en) * 1968-09-03 1975-01-21 Entrapment compositions and processes
DE2732335C2 (en) * 1976-07-27 1983-01-20 Sandoz-Patent-GmbH, 7850 Lörrach Tablet for the enteral administration of indolyloxyalkanolamine derivatives
IL53462A (en) * 1976-11-26 1980-12-31 Pennwalt Corp Prolonged release pharmaceutical preparations containing ion exchange drug complexes
DE3930733A1 (en) * 1989-09-14 1991-03-28 Roehm Gmbh METHOD FOR PRODUCING A COMPLEX MEDICINAL PRODUCT
NL9002336A (en) * 1990-10-24 1992-05-18 Leuven K U Res & Dev COATING OR MATRIX MATERIAL FOR MEDICINES.
PL1735006T3 (en) * 2004-04-05 2008-02-29 Basf Se Polymer particles containing active agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
CH468192A (en) * 1964-06-19 1969-02-15 Ciba Geigy Process for the manufacture of medicaments in pearl form

Also Published As

Publication number Publication date
CA927282A (en) 1973-05-29
FR2017311A1 (en) 1970-05-22
DE1944693C3 (en) 1978-08-24
DE1944693B2 (en) 1977-12-22
DE1944693A1 (en) 1970-04-30
MY7300483A (en) 1973-12-31

Similar Documents

Publication Publication Date Title
AU428130B2 (en)
AU6168869A (en)
FR2017311B1 (en)
AU6171569A (en)
AU416157B2 (en)
AU429879B2 (en)
JPS56406B1 (en)
AU421558B1 (en)
AU3224368A (en)
AU3789668A (en)
BE725602A (en)
BE709446A (en)
AU4558658A (en)
BE728381A (en)
BE728345A (en)
BE727774A (en)
BE727296A (en)
BE727285A (en)
BE726639A (en)
AU4224469A (en)
BE726599A (en)
BE726501A (en)
BE726500A (en)
BE709479A (en)
BE724513A (en)

Legal Events

Date Code Title Description
ST Notification of lapse